急性肾损伤后风险预测模型的验证以指导临床决策
该研究外部验证了两种AKI后风险模型(Grampian-AKI再入院模型和Alberta-CKD G4-G5风险模型),并采用决策曲线分析比较基于风险模型的临床决策与替代策略的净获益。结果显示两种模型区分度良好(AUC分别为0.77和0.86),且基于模型的决策净获益优于其他策略;多数情况下随访所有AKI患者比仅随访严重AKI患者净获益更大。
要点
- 两种AKI后风险模型区分度良好,AUC分别为0.77和0.86。
- 决策曲线分析显示基于风险模型的决策净获益优于其他策略。
- 多数情况下随访所有AKI患者比仅随访严重AKI患者净获益更大。
核心结论
- AKI后随访对预防再入院、死亡和后续CKD进展具有潜在净获益。
- 使用风险模型并关注全谱系严重程度的AKI可改善临床决策。
研究设计与样本
- 研究为两种AKI结局风险模型的外部验证:Grampian-AKI再入院模型和Alberta-CKD G4-G5风险模型。
- 验证基于2011-2013年Grampian成人AKI住院幸存者数据,并采用过程挖掘描绘现有护理路径。
主要发现
- 死亡或再入院模型验证纳入26,575例(平均年龄60.9±19.8岁),CKD G4-G5模型验证纳入9,382例(平均年龄60.9±19.8岁)。
- 两模型区分度良好,AUC分别为0.77和0.86。
- 决策曲线分析显示多数情况下随访所有AKI患者比仅随访严重AKI患者净获益更大。
- 原始模型和重新拟合模型提供的净获益均优于任何其他决策策略。
- 过程挖掘显示41%的再入院和死亡发生在AKI后恢复期患者中,且3,776例AKI后再入院患者中1,464例(39%)未接受 intervening monitoring。
关键数值与推荐
- 死亡或再入院结局定义为所有住院幸存者90天内死亡或再入院。
- CKD进展结局定义为AKI后存活至少90天的患者进展至新发CKD G4-G5。
- 预测因子为原模型指定的基于KDIGO的AKI严重程度指标和合并症。
临床怎么用
- 临床可考虑使用经验证的风险模型来指导AKI后随访决策。
- 随访策略应覆盖全谱系严重程度的AKI患者,而非仅限严重AKI。
- 对AKI后恢复期患者也应加强监测,以减少再入院和死亡。
局限性
- 两个原始模型均高估了风险,提示需要定期更新。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: There is limited evidence to guide follow-up after acute kidney injury (AKI). Knowledge gaps include which patients to prioritize, at what time point, and for mitigation of which outcomes. In this study, we sought to compare the net benefit of risk model-based clinical decisions following AKI. STUDY DESIGN: External validation of 2 risk models of AKI outcomes: the Grampian -Aberdeen (United Kingdom) AKI readmissions model and the Alberta (Canada) kidney disease risk model of chronic kidney disease (CKD) glomerular (G) filtration rate categories 4 and 5 (CKD G4 and G5). Process mining to delineate existing care pathways. SETTING & PARTICIPANTS: Validation was based on data from adult hospital survivors of AKI from Grampian, 2011-2013. PREDICTORS: KDIGO-based measures of AKI severity and comorbidities specified in the original models. OUTCOMES: Death or readmission within 90 days for all hospital survivors. Progression to new CKD G4-G5 for patients surviving at least 90 days after AKI. ANALYTICAL APPROACH: Decision curve analysis to assess the "net benefit" of use of risk models to guide clinical care compared to alternative approaches (eg, prioritizing all AKI, severe AKI, or only those without kidney recovery). RESULTS: 26,575 of 105,461 hospital survivors in Grampian (mean age, 60.9 ± 19.8 [SD] years) were included for validation of the death or readmission model, and 9,382 patients (mean age, 60.9 ± 19.8 years) for the CKD G4-G5 model. Both models discriminated well (area under the curve [AUC], 0.77 and 0.86, respectively). Decision curve analysis showed greater net benefit for follow up of all AKI than only severe AKI in most cases. Both original and refitted models provided net benefit superior to any other decision strategy. In process mining of all hospital discharges, 41% of readmissions and deaths occurred among people recovering after AKI. 1,464 of 3,776 people (39%) readmitted after AKI had received no intervening monitoring. LIMITATIONS: Both original models overstated risks, indicating a need for regular updating. CONCLUSIONS: Follow up after AKI has potential net benefit for preempting readmissions, death, and subsequent CKD progression. Decisions could be improved by using risk models and by focusing on AKI across a full spectrum of severity. The current lack of monitoring among many with poor outcomes indicates possible opportunities for implementation of decision support.
引用
- Sawhney S, Tan Z, Black C, et al. Validation of Risk Prediction Models to Inform Clinical Decisions After Acute Kidney Injury. Am J Kidney Dis. 2021. PMID: 33428996. doi:10.1053/j.ajkd.2020.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。